A Trial to Evaluate the Efficacy and Safety of Tafasitamab With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The purpose of the study is to compare the safety and efficacy of Tafasitamab with BEN versus RTX with BEN in adult patients with relapsed of refractory DLBCL.
Epistemonikos ID: f386b01014b08d1135620e3b78d788bcb1e7e2e5
First added on: May 13, 2024